Measles Research Today is a free monthly online journal that collates and summarizes the latest research about Measles, including details on german measles, symptoms, vaccine, treatment, rubella.

Volume 3 (2006), Issue 12 (December)

1. Improvement of child survival in Mexico: the diagonal approach.
   Lancet, 368(9551): 2017-27. [Abstract] [Full-text]
2. Engineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinoma.
   Hepatology, 44(6): 1465-77. [Abstract] [Full-text]
3. Profound bilateral sensorineural hearing loss in nigerian children: any shift in etiology?
   J Deaf Stud Deaf Educ, 12(1): 112-8. [Abstract] [Full-text]
4. Associations between measles vaccine immunity and single-nucleotide polymorphisms in cytokine and cytokine receptor genes.
   J Infect Dis, 195(1): 21-9. [Abstract] [Full-text]
5. Vaccine adverse events reported in post-marketing study of the Kitasato Institute from 1994 to 2004.
   Vaccine, 25(3): 570-6. [Abstract] [Full-text]
6. Increased risk of chronic suppurative lung disease after measles or pertussis in non-vaccinated children.
   Vaccine, 25(3): 402-3. [Abstract] [Full-text]
7. Immunization coverage and its determinants in children aged 12-23 months in Gansu, China.
   Vaccine, 25(4): 664-71. [Abstract] [Full-text]
8. Infected cell carriers: a new strategy for systemic delivery of oncolytic measles viruses in cancer virotherapy.
   Mol Ther, 15(1): 114-22. [Abstract] [Full-text]
9. Prophylactic antibiotics to prevent pneumonia and other complications after measles: community based randomised double blind placebo controlled trial in Guinea-Bissau.
   BMJ, 333(7581): 1245. [Abstract] [Full-text]
10. Promoting measles vaccination in attendees not yet immunized at day-care centers in Kyoto City.
    Pediatr Int, 48(6): 555-61. [Abstract] [Full-text]
11. Mapping of B cell epitopes in measles virus nucleocapsid protein.
    Arch Virol, 152(1): 25-39. [Abstract] [Full-text]
12. Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE.
    Clin Immunol, 122(1): 62-74. [Abstract] [Full-text]
13. Retargeted oncolytic measles strains entering via the EGFRvIII receptor maintain significant antitumor activity against gliomas with increased tumor specificity.
    Cancer Res, 66(24): 11840-50. [Abstract] [Full-text]
14. The ages of suspicion, diagnosis, amplification, and intervention in deaf children.
    Int J Pediatr Otorhinolaryngol, 71(1): 35-40. [Abstract] [Full-text]
15. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Cytometry B Clin Cytom, 72(1): 14-21. [Abstract] [Full-text]
16. Evaluation of Twenty Human Adenoviral Types and One Infectivity-Enhanced Adenovirus for the Therapy of Soft Tissue Sarcoma.
    Hum Gene Ther. [Abstract] [Full-text]

© 2004-2011 Measles Research Today. All Rights Reserved.